Answers are grounded in this paper and cite their sources.
The IVT mRNA-based reactivation of p53 holds promise as a potential therapeutic strategy for HGSOC, providing valuable insights into the molecular mechanisms underlying p53 function and its relevance in ovarian cancer treatment.
No takes yet. Share an insight, caveat, or question.
Raab et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: